VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 132 filers reported holding VERASTEM INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $17,206 | -71.8% | 12,203 | -59.0% | 0.00% | 0.0% |
Q4 2021 | $61,078 | +14.7% | 29,794 | +72.3% | 0.00% | 0.0% |
Q3 2021 | $53,244 | -62.6% | 17,287 | -50.5% | 0.00% | -50.0% |
Q2 2021 | $142,190 | +8.9% | 34,936 | -33.9% | 0.00% | 0.0% |
Q1 2021 | $130,604 | +25.2% | 52,876 | +8.0% | 0.00% | 0.0% |
Q4 2020 | $104,281 | +74.2% | 48,958 | -1.0% | 0.00% | +100.0% |
Q3 2020 | $59,848 | -37.6% | 49,461 | -11.4% | 0.00% | -50.0% |
Q2 2020 | $95,973 | +21.3% | 55,798 | +137.0% | 0.00% | 0.0% |
Q4 2018 | $79,098 | -53.7% | 23,541 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $170,672 | -99.9% | 23,541 | +24.9% | 0.00% | +50.0% |
Q2 2018 | $129,688,000 | +301500.0% | 18,850 | -20.7% | 0.00% | – |
Q3 2015 | $43,000 | -70.5% | 23,771 | +23.1% | 0.00% | -100.0% |
Q2 2015 | $146,000 | -40.7% | 19,316 | -20.3% | 0.00% | -50.0% |
Q1 2015 | $246,000 | +38.2% | 24,222 | +54.7% | 0.00% | +100.0% |
Q4 2013 | $178,000 | +13.4% | 15,656 | +24.0% | 0.00% | 0.0% |
Q3 2013 | $157,000 | -10.3% | 12,628 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $175,000 | – | 12,628 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |